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Editor’s Note: This article is in response to a very important
practical problem surrounding FNA of the thyroid. This pro-
cedure can be performed in a doctor’s office, an outpatient
FNA clinic, a radiological suite, intraoperatively, and in vari-
ous other settings. The person doing the procedure also can
be a number of specialists: cytopathologists, endocrinologists,
general surgeons, head and neck physicians, and severa1
other practitioners. Almost everyone agrees that immediate
assessment has a role in this procedure. Exactly what role
that is and how important its impact constitutes the purpose
of this article.
Immediate adequacy assessment (IADA) during fine-needle aspi-
ration (FNA) is not universal and the optimal number of passes
has not been well determined. The aim of this study was to eval-
uate the nondiagnostic rates (NDR) with and without the IADA
for thyroid aspirates. Subsequent cytological and surgical fol-
low-up were reviewed for nondiagnostic cases. In addition, we
evaluated the number of passes performed in each FNA to deter-
mine the optimal number.
Retrospective analysis of NDR was performed on 883 thyroid
FNA specimens retrieved through a Computer SNOMED Search
from our files between January 2001 to December 2003. For
FNAs with IADA, one Diff-Quick and one fixed smear for each
pass were prepared, and the needle was rinsed in CytoLyt solu-
tion for a ThinPrep and/or a cell-block. FNAs without IADA
were received in CytoLyt solution, from which a ThinPrep and a
cell-block were prepared for each case.
Of the total 883 cases, 443 were performed with IADA, of
which 417 cases were diagnostic. The remaining 440 cases were
performed without IADA, of which 300 cases were diagnostic.
NDR for IADA was 5.9% (26 cases-group-I) compared to 31.8%
(140 cases-group-II) without IADA. In group-I, 5 cases were
followed-up by repeat FNA, 10 cases by surgical resection, and
11 cases received no tissue follow-up. In group-II, 23 cases were
followed-up by repeat FNA, 36 by surgical resection, and
82 cases received no tissue follow-up. Interestingly, follow-up in
group-I did not reveal any missed malignancy, while that in
group-II resulted in a malignant diagnosis in 13.8% (8 cases).
We also found that the optimal number of passes with least
NDR was 4–6 passes. NDR was 25% for < 3 passes, 11% for
4 passes, 5.2% for 5 passes, 1.4% for 6 passes, and 2.5% for
7 passes or more. IADA significantly reduces the NDR and
increases the sample adequacy for diagnosis. Optimal number of
passes is 4–6 passes, and additional passes did not improve the
diagnostic rate. Our study also emphasizes the significance of
repeat FNA or histological follow-up for nondiagnostic cases,
especially for those without IADA. Diagn. Cytopathol. 2007;
35:183–186. ' 2007 Wiley-Liss, Inc.
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Thyroid lesions (TLs) are a common clinical problem.
Fine-needle aspiration (FNA) of the thyroid is now a
widely accepted, simple diagnostic method, that proved to
be a safe, efficient, reliable, and cost-effective diagnostic
procedure to triage TLs for the surgical excision or conser-
vative management.1,2 While immediate adequacy assess-
ment (IADA) during fine-needle aspiration (FNA) could
be the key for its diagnostic success, it is not universally
applied.3–7 Our study was designed to determine whether
onsite adequacy assessment significantly decreases the
nondiagnostic rate (NDR) in the thyroid FNA. Since the
management of initial nondiagnostic cases has not been
well established and nondiagnostic FNAs of thyroid nod-
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ules remain a significant clinical dilemma,8–11 we also
investigated the significance of performing a repeat biopsy
for those initial nondiagnostic cases by subsequently re-
viewing cytological and surgical following up. In addi-
tion, knowledge of the optimal number of fine needle
passes could impact diagnostic accuracy, which has not
been well determined.2,7 As the second purpose of this
study, we evaluated the number of passes per aspirate to
determine the optimal number of FNA passes required to
obtain an accurate cytologic diagnosis.
Methods
Retrospective analysis of NDR was performed on 883
thyroid FNA specimens retrieved through a Computer
SNOMED Search from our files from January 2001 to
December 2003 at University of Michigan Hospitals. For
FNAs with IADA of cytopathology, one Diff-Quick and
one fixed smear for each pass were prepared and the nee-
dle was rinsed in CytoLyt1 solution for a ThinPrep and/
or a cell-block. Immediate cytologic examination was per-
formed by a cytopathology fellow and/or cytotechnolo-
gists and a faculty. When immediate cytologic assessment
was not done, the FNA material was received in CytoLyt
solution, from which a ThinPrep and a cell-block were
prepared for each case.
The nondiagnostic rate was defined as the number of
inadequate cases expressed as a percentage of the total
number of cases. Inadequate cases were those that were
unsatisfactory for reporting/or unable to offer any diagno-
sis for reasons including either paucity of cells or any
other technical reason such as air-drying, crush artifact,
obscuring blood, cells being trapped in fibrin clots and so
on. Some initially nondiagnostic cases were followed up
with repeat FNAs or biopsies. The statistical significance
of the findings was analyzed using Student’s t or v2 tests;
P values of 0.05 or less were considered significant.
Results
The total numbers of FNA cases and percentages [non-
diagnostic rate (NDR)] of nondiagnostic cases are given
in Table I. The total number of inadequate samples was
166/883 cases, giving an overall NDR of 18.8%. A total
of 883 cases were divided into the two main categories,
with and without immediate adequacy assessment (IADA)
by cytopathologists. Of the 443 with IADA by cytopatho-
logists (group I), 26 cases were nondiagnostic, giving a
nondiagnostic rate of 5.9%. In contrast, of the 440 cases
without immediate adequacy assessment (Non-IADA-
group II), there were 140 nondiagnostic cases resulting in
a nondiagnostic rate of 31.8%. On site evaluation by cyto-
pathologists significantly reduced the NDR of thyroid
FNAs (P < 0.001). Table II summarizes the distribution
of FNA diagnoses for the diagnostic aspirates in the two
groups. As in previous reports, the most common diagno-
sis is nodular hyperplasia, comprising 70% of cases.
There is no significant difference in the distribution of
FNA diagnoses between the two groups to account for the
difference in the diagnostic rate.
In group I with IADA, 20 of the 443 cases had 3 or
less passes per case. Of those 20 cases, 5 cases were non-
diagnostic with a nondiagnostic rate of 25%. The NDR
was reduced to 11.0% (P < 0.001) by performing 4 FNA
passes. Our data also demonstrated a continuous reduction
of NDR with the increase in number of FNA passes up to
6 passes. However, additional passes beyond that did not
show a significant improvement of NDR (Table III).
Further follow-up by either repeat FNA or surgical
resection was available in 14 of the 26 nondiagnostic
cases in the FNA group with IADA/group I (Table IV).
There was no missed malignant neoplasm identified in the
follow-up. In the contrast, of the 140 nondiagnostic cases
without IADA/group II, 58 cases had additional follow-
up. Seven initially nondiagnostic cases were diagnosed as
papillary thyroid carcinoma (12.1%), one case as Hurthle
cell carcinoma (1.7%), and two cases as follicular
neoplasm (3.4%). The overall incidence of malignant neo-
plasm in the initial nondiagnostic cases is 11% (8/73).
About 10–15% of cases that received a repeat FNA for
follow-up remained nondiagnostic.







IADA 443 26 5.9*
Non-IADA 440 140 31.8*
Total 883 166 18.8
*P < 0.001.
Table II. Cytological Diagnosis in Thyroid Aspirates
Total cases (%)
IADA Non-IADA
ATC 2 (0.5) 1 (0.3)
FN 39 (9.4) 16 (5.3)
HT 9 (2.2) 3 (1.0)
HCN 12 (2.9) 5 (1.7)
ID 2 (0.5) 0 (0)
LT 15 (3.6) 19 (6.4)
LYM 2 (0.5) 3 (1.0)
MTC 1 (0.2) 3 (1.0)
NH 285 (68.3) 232 (77.3)
PTC 50 (12.0) 18 (6.0)
Total 417 (100) 300 (100)
ATC, anaplastic thyroid carcinoma; FN, follicular neoplasm; FA, follicu-
lar adenoma; HCA, Hurthle cell adenoma; HCCa, Hurthle cell carci-
noma; HCN, Hurthle cell neoplasm; HT, Hashimoto’s thyroiditis; IADA,
immediate adequacy assessment; ID, inflammatory disease; LT, lympho-
cytic thyroditis; LYM, lymphoma; MTC, medullary thyroid carcinoma;
NDR, Nondiagnostic rate; NH, nodular hyperplasia; Non-IADA, non-
immediate adequacy assessment; PTC, papillary thyroid carcinoma.
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Discussion
It has been reported that the immediate adequacy assess-
ment of thyroid FNAs has resulted in measurable cost
savings by reducing the rate of nondiagnostic aspirates
and therefore avoiding the need for repeat FNA.4–7 How-
ever, other authors claimed that there was no significant
difference in cytologic adequacy whether immediate cyto-
logic assessment of aspirated material was performed or
not if the FNA is performed under US guidance, and that
on-site adequacy evaluation will prolong procedure time,
increases patient discomfort, and waste valuable cytologi-
cal and radiological resources.12 Our study demonstrated
that the immediate cytologic assessment of thyroid FNAs
significantly reduces the number of nondiagnostic cases.
The contribution of the cytology assessment significantly
reduced the problem of inadequate samples, as also
reported by others.3 The certainty of having obtained an
adequate sample limits the number of passes per FNA and
reduces the need for repeat aspiration on the same patient
to successfully obtain an adequate sample. This also pro-
vides great cost savings as it reduces the cost associated
with second hospital visits and additional procedures.6
On-site immediate evaluation of FNA specimens also pro-
vides the appropriate sample triage for ancillary studies
and the ability to issue a preliminary diagnosis, which
often facilitates rapid clinical decisions.4–6
The immediate assistance by cytology during FNA is
not universal, and the optimal number of fine needle
passes during the FNA has not been well documented.2,7
Although FNA of the thyroid is considered to have a high
diagnostic efficiency, it largely depends on the aspirator’s
and the cytologist’s expertise.9,13,14 One of the goals in
this study was to determine the optimal number of fine
needle passes required to reach a diagnosis with certainty.
An optimal number would be particularly useful in insti-
tutions in which the assistance by cytology is not avail-
able. Our study revealed that when the number of needle
passes is 3 or less, the NDR could be 25% or more. NDR
was significantly reduced to 11% with 4 passes performed
per thyroid lesions. This suggests that 4 passes/lesion
should be the minimum number to reach a reasonable
diagnostic rate. Our study also revealed that 6 passes/
nodule demonstrated a very low NDR of 1.5%, which
was not improved upon additional passes. Our findings
are in agreement with those suggesting 4–6 passes per
thyroid nodule as the optimal number of passes needed to
maximize diagnostic certainty, in the presence of immedi-
ate assessment of specimens by a cytopathologist,9,13,14
and confirms that it would provide an optimal yield within
the limits of practicality. Multiple passes are particularly
important when immediate adequacy assessment is not
available.
Although the nondiagnostic rate of FNA is reported to
be lower with ultrasound-guided FNA, there are 10–20%
cases continuing to be nondiagnostic.15,16 In our study, the
incidence of malignancy is 11% among initial nondiag-
nostic FNA cases, which is in agreement with the previ-
ous reports.10,11 There are about 15% cases remaining to
be nondiagnostic despite repeat FNA with IADA. Our
data supports the opinion that initial nondiagnostic cases
particularly those in the group with no IADA should be
repeated due to the high potential of malignancy.8,10,11
References
1. AACE/AME Task Force on Thyroid Nodules. American Associa-
tion of Clinical Endocrinologists and Associazione Medici Endocri-
nologi medical guidelines for clinical practice for the diagnosis and
management of thyroid nodules. Endocr Pract 2006;12:63–102.
2. Nguyen G-K, Lee MW, Ginsberg J, Wragg T, Bilodeau D. Fine-
needle aspiration of the thyroid: An overview. Cytojournal 2005;
2:12.
3. Austin JHM, Cohen MB. Value of having cytopathologist present
during percutaneous fine-needle aspiration biopsy of lung: Report
of 55 cancer patients and meta-analysis of the literature. AJR Am
J Roentgenol 1993;160:175–177.
4. Civardi G, Fornari F, Cavanna L, Di Stasi M, Sbolli G, Buscarini
L. Value of rapid staining and assessment of ultrasound-guided fine
needle aspiration biopsies. Acta Cytol 1988;32:552–554.
5. Ghofrani M, Beckman D, Rimm DL. The value of onsite adequacy
assessment of thyroid fine-needle aspirations is a function of opera-
tor experience. Cancer 2006;108:110–113.
6. Nasuti JF, Gupta PK, Baloch ZW. Diagnostic value and cost-effec-
tiveness of on-site evaluation of fine-needle aspiration specimens:
Review of 5, 688 cases. Diagn Cytopathol 2002;27:1–4.









3 20 5 25.0
4 100 11 11.0
5 115 6 5.2
6 67 1 1.4
7 39 1 2.5
8 102 2 2.0




NH 4 (15.5) 14 (10.0)
FN 0 (0) 2 (1.4)
PTC 0 (0) 3 (2.1)
ND 1 (3.8) 3 (2.1)
Histological follow-up
NH 7 (26.9) 24 (17.8)
HT & LT 1 (3.8) 3 (2.1)
FA 2 (7.7) 3 (2.1)
HCA 0 (0) 1 (0.7)
HCCa 0 (0) 1 (0.7)
PTC 0 (0) 4 (2.9)
Non-follow-up 11 (42.3) 82 (58.6)
Total 26 (100) 140 (100)
ON-SITE ADEQUACY ASSESSMENT FOR THYROID FNA
Diagnostic Cytopathology, Vol 35, No 3 185
Diagnostic Cytopathology DOI 10.1002/dc
7. Eedes CR, Wang HH. Cost-effectiveness of immediate specimen
adequacy assessment of thyroid fine-needle aspirations. Am J Clin
Pathol 2004;121:64–69.
8. Alexander EK, Heering JP, Benson CB, et al. Assessment of
nondiagnostic ultrasound-guided fine needle aspirations of thyroid
nodules. J Clin Endocrinol Metab 2002;87:4924–4927.
9. Hall TL, Layfield LJ, Phillip A, Rosenthal D. Sources of diagnostic
error in fine needle aspiration of the thyroid. Cancer 1989;63:718–
725.
10. McHenry CR, Walfish PG, Rosen IB. Non-diagnostic fine needle
aspiration biopsy: A dilemma in management of nodular thyroid
disease. Am Surg 1993;59:415–419.
11. Chow LS, Gharib H, Goellner JR, van Heerden JA. Nondiagnostic
thyroid fine-needle aspiration cytology: Management dilemmas.
Thyroid 2001;11:1147–1151.
12. O’Malley ME, Weir MM, Hahn PF, Misdraji J, Wood BJ, Mueller
PR. US-guided fine-needle aspiration biopsy of thyroid nodules:
Adequacy of cytologic material and procedure time with and with-
out immediate cytologic analysis. Radiology 2002;222:383–387.
13. Gharib H, Goellner J. Fine needle aspiration biopsy of the thyroid:
An appraisal. Ann Intern Med 1993;118:282–289.
14. Hamburger B, Gharib H, Melton LJ, Goellner JR, Zinsmeister AR.
Fine needle aspiration biopsy of the thyroid nodules. Impact on
thyroid practice and cost care. Am J Med 1982;73:381–384.
15. Danese D, Sciacchitano S, Farsetti A, Andreoli M, Pontecorvi A.
Diagnostic accuracy of conventional versus sonography-guided fine-
needle aspiration biopsy of thyroid nodules. Thyroid 1998;8:15–21.
16. Marqusee E, Benson CB, Frates MC, et al. Usefulness of ultraso-
nography in the management of nodular thyroid disease. Ann Intern
Med 2000;133:696–700.
ZHU AND MICHAEL
186 Diagnostic Cytopathology, Vol 35, No 3
Diagnostic Cytopathology DOI 10.1002/dc
